Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Terminated × Has announcements × N-Methyl-3,4-methylenedioxyamphetamine × Clear all

Sponsor

Interventions

TIC10 compound 3 trastuzumab deruxtecan 2 umbralisib 1 ublituximab 1 duvelisib 1 blinatumomab 1 belumosudil 1 Rituximab 1 KD025 1 Crizotinib 1 Bendamustine Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡